MedTrace Logo

Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery Patients

NCT02646072 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2016-01-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether there is a relationship between inflammatory cytokines in the aqueous of the eye and thickness of the macula after treatment of topical ketorolac for patients undergoing cataract surgery.

Conditions

Interventions

DRUG

Ketorolac tromethamine ophthalmic solution 0.45%

Indicated for the treatment of pain and inflammation following cataract surgery.

Sponsors & Collaborators

  • University of Malaya

    lead OTHER

Principal Investigators

  • Yin Peng Lai, MOphthal · University of Malaya

  • Mohammadreza Peyman, Mophthal · University of Malaya

  • Tajunisah Iqbal, FRCS Ophth · University of Malaya

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-05-31
Completion
2015-06-30

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02646072 on ClinicalTrials.gov